LEMTRADA 12 mg/1.2mL
ALEMTUZUMAB · INJECTION, SOLUTION, CONCENTRATE · Genzyme Corporation
No Recall History
Plain English
LEMTRADA is a injection, solution, concentrate containing alemtuzumab at 12 mg/1.2mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- LEMTRADA
- Generic Name
- ALEMTUZUMAB
- NDC Code (Product)
58468-0200- Manufacturer
- Genzyme Corporation
- Strength
- 12 mg/1.2mL
- Dosage Form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA103948
- Drug Class
- CD52-directed Cytolytic Antibody [EPC]
- Marketing Start
- 11/18/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is LEMTRADA used for?
LEMTRADA contains ALEMTUZUMAB. It is a injection, solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is LEMTRADA a controlled substance?
LEMTRADA is not classified as a controlled substance by the DEA.
What is the generic name for LEMTRADA?
The generic name for LEMTRADA is ALEMTUZUMAB. There are 1 other brand versions of ALEMTUZUMAB.
What is the NDC code for LEMTRADA 12 mg/1.2mL?
The NDC (National Drug Code) for LEMTRADA 12 mg/1.2mL is 58468-0200, listed by Genzyme Corporation.